← Back to Search

Communication Strategies for Children With Medical Complexity

N/A

Recruiting

Led By Jody L Lin, MD, MS

Research Sponsored by University of Utah

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediately after reviewing the intervention

Awards & highlights

Study Summary

This trial will test different ways to communicate medical info to the caregivers of kids w/ medical complexity to help them make the best decisions.

Who is the study for?

This trial is for adult caregivers of children with complex medical conditions. Participants must be able to speak English or Spanish. It's designed to help understand how best to communicate about treatment risks and benefits, aiming to improve decision-making quality.Check my eligibility

What is being tested?

The study tests different communication strategies by having participants view a video simulating a clinic visit and then complete a survey. The goal is to see if the way information is presented affects the decisions caregivers make for their children.See study design

What are the potential side effects?

Since this trial involves watching videos and completing surveys rather than testing medications, there are no direct physical side effects associated with participating in this research.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ immediately after reviewing the intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~immediately after reviewing the intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after reviewing the intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Decision readiness

Secondary outcome measures

Decision intent for treatment

Decisional Conflict Scale

Knowledge

Trial Design

16Treatment groups

Experimental Treatment

Active Control

Group I: Normalizing onlyExperimental Treatment1 Intervention

Receive information about normalizing language related to the clinical decision.

Group II: Normalizing and narratives onlyExperimental Treatment2 Interventions

Receive information about normalizing language and narratives related to the clinical decision.

Group III: Narratives onlyExperimental Treatment1 Intervention

Receive narratives in addition to the control condition.

Group IV: Complexity, normalizing, and narratives onlyExperimental Treatment3 Interventions

Receive information about complexity, normalizing language, and narratives related to the clinical decision.

Group V: Complexity onlyExperimental Treatment1 Intervention

Receive information about complexity related to the clinical decision.

Group VI: Complexity and normalizing onlyExperimental Treatment2 Interventions

Receive information about complexity and normalizing language related to the clinical decision.

Group VII: Complexity and narratives onlyExperimental Treatment2 Interventions

Receive information about complexity and narratives related to the clinical decision.

Group VIII: Ambiguity, normalizing, and narratives onlyExperimental Treatment3 Interventions

Receive information about ambiguity, normalizing language, and narratives related to the clinical decision.

Group IX: Ambiguity, complexity, and normalizing onlyExperimental Treatment3 Interventions

Receive information about ambiguity, complexity, and normalizing language related to the clinical decision.

Group X: Ambiguity, complexity, and narratives onlyExperimental Treatment3 Interventions

Receive information about ambiguity, complexity, and narratives related to the clinical decision.

Group XI: Ambiguity onlyExperimental Treatment1 Intervention

Receive information about ambiguity related to the clinical decision.

Group XII: Ambiguity and normalizing onlyExperimental Treatment2 Interventions

Receive information about ambiguity and normalizing language related to the clinical decision.

Group XIII: Ambiguity and narratives onlyExperimental Treatment2 Interventions

Receive information about ambiguity and narratives related to the clinical decision.

Group XIV: Ambiguity and complexity onlyExperimental Treatment2 Interventions

Receive information about ambiguity and complexity related to the clinical decision.

Group XV: AllExperimental Treatment4 Interventions

Receive all new communication approaches

Group XVI: ControlActive Control1 Intervention

No new communication approaches received.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Narrative

2017

N/A

~340

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor

1,100 Previous Clinical Trials

1,778,165 Total Patients Enrolled

Children's Hospital Los AngelesOTHER

232 Previous Clinical Trials

5,075,788 Total Patients Enrolled

Jody L Lin, MD, MSPrincipal InvestigatorUniversity of Utah

Media Library

Normalizing and narratives only Clinical Trial Eligibility Overview. Trial Name: NCT05913206 — N/A

Comorbidity Research Study Groups: Normalizing and narratives only, Ambiguity, normalizing, and narratives only, Complexity, normalizing, and narratives only, Ambiguity and normalizing only, Ambiguity, complexity, and normalizing only, Ambiguity and narratives only, Ambiguity, complexity, and narratives only, Narratives only, Complexity and narratives only, Normalizing only, Ambiguity and complexity only, Ambiguity only, Control, All, Complexity only, Complexity and normalizing only

Comorbidity Clinical Trial 2023: Normalizing and narratives only Highlights & Side Effects. Trial Name: NCT05913206 — N/A

Normalizing and narratives only 2023 Treatment Timeline for Medical Study. Trial Name: NCT05913206 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is participation in this investigation open to the public?

"According to clinicaltrials.gov, recruitment for this medical trial has concluded as of June 12th 2023 since the initial posting date on June 1st. Nonetheless, there are still 113 other studies that need participants right now."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Understanding Factors in Decision Making for Children With Medical Complexity

2023. "Understanding Factors in Decision Making for Children With Medical Complexity". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05913206.